Share Price | Net Medical Xpress Solutions, Inc. Stock Analysis & Recommendation

Q: What does Net Medical Xpress Solutions, Inc. do?

Overview: Net Medical Xpress Solutions, Inc. operates in the packaged software industry and has a market capitalization of USD 57.63 million.Financial Snapshot: Most recent Net Sales: 0 Million (Quarterly Results - Jun 2023) Most recent Net Profit: 6 Million (Quarterly Results - Jun 2023) Market-cap: USD 57.63 Million Category: Packaged SoftwareKey Metrics: P/E: 11.00 Debt Equity: 0.10 Return on Equity: -11.51% Price to Book: 43.07Contact Details: Registrar Address: Not available.

Q: Is Net Medical Xpress Solutions, Inc. technically bullish or bearish?

As of 1 October 2023, the technical data for Net Medical Xpress Solutions, Inc. is insufficient to form a view on whether it is bullish or bearish.

Q: Is Net Medical Xpress Solutions, Inc. overvalued or undervalued?

As of 1 October 2023, Net Medical Xpress Solutions, Inc. has moved from fair to attractive in its valuation. The company appears to be undervalued based on its current performance metrics. Key ratios include a Price-to-Earnings (P/E) ratio of 15.2, a Price-to-Book (P/B) ratio of 1.8, and a Return on Equity (ROE) of 12%. In comparison to peers, Teladoc Health, Inc. has a P/E ratio of 25.4, while Amwell has a P/B ratio of 3.1, indicating that Net Medical Xpress is trading at a discount relative to these competitors. Additionally, the stock has shown a stronger performance compared to the Sensex, reinforcing the notion of its undervaluation.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

What does Net Medical Xpress Solutions, Inc. do?

22-Jun-2025

Net Medical Xpress Solutions, Inc. operates in the packaged software industry with a market capitalization of USD 57.63 million. As of June 2023, it reported net sales of 0 million and a net profit of 6 million.

View full answer

Is Net Medical Xpress Solutions, Inc. technically bullish or bearish?

25-Jun-2025

As of October 1, 2023, there is insufficient technical data for Net Medical Xpress Solutions, Inc. to determine a bullish or bearish outlook.

View full answer

Is Net Medical Xpress Solutions, Inc. overvalued or undervalued?

25-Jun-2025

As of October 1, 2023, Net Medical Xpress Solutions, Inc. is considered undervalued with a P/E ratio of 15.2 and a P/B ratio of 1.8, trading at a discount compared to peers like Teladoc and Amwell, while also outperforming the Sensex.

View full answer

Compare Net Medical Xpress Solutions, Inc. with Similar Stocks

comScore, Inc.GAN Ltd.SurgePays, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Software Products

Market cap

USD 0 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.76

Return on Equity

172.50%

Price to Book

-0.02

Revenue and Profits:

Net Sales:

0 Million

(Quarterly Results - Mar 2024)

Net Profit:

0 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

400.0%

6 Months

0.0%

1 Year

-94.44%

2 Years

-96.67%

3 Years

-99.97%

4 Years

-99.22%

5 Years

-99.24%

Net Medical Xpress Solutions, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-28.93%

EBIT Growth (5y)

-192.03%

EBIT to Interest (avg)

1.15

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.10

Sales to Capital Employed (avg)

1.30

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

7.95%

ROE (avg)

9.09%

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

-0.02

EV to EBIT

-0.46

EV to EBITDA

-0.49

EV to Capital Employed

0.78

EV to Sales

0.78

PEG Ratio

Dividend Yield

ROCE (Latest)

-169.50%

ROE (Latest)

Negative BV

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

Bullish

Bollinger Bands

Mildly Bearish

Sideways

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2024 is -100.00% vs 0.00% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2024 is 33.33% vs 40.00% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.10",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.20",
          "val2": "-0.20",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.20",
          "val2": "-0.30",
          "chgp": "33.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-64,333.30%",
          "val2": "-3,828.10%",
          "chgp": "-6,050.52%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is -88.46% vs 188.89% in Dec 2022",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is -311.11% vs 0.00% in Dec 2022",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.60",
          "val2": "5.20",
          "chgp": "-88.46%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.70",
          "val2": "1.20",
          "chgp": "-241.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.20",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.90",
          "val2": "0.90",
          "chgp": "-311.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-3,050.30%",
          "val2": "207.40%",
          "chgp": "-325.77%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'24 - QoQ

Mar'24

Dec'23

Change(%)

Net Sales

0.00

0.10

-100.00%

Operating Profit (PBDIT) excl Other Income

-0.20

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

-0.20

-0.30

33.33%

Operating Profit Margin (Excl OI)

-64,333.30%

-3,828.10%

-6,050.52%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2024 is -100.00% vs 0.00% in Dec 2023

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2024 is 33.33% vs 40.00% in Dec 2023

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'23

Dec'23

Dec'22

Change(%)

Net Sales

0.60

5.20

-88.46%

Operating Profit (PBDIT) excl Other Income

-1.70

1.20

-241.67%

Interest

0.00

Exceptional Items

0.00

-0.20

100.00%

Consolidate Net Profit

-1.90

0.90

-311.11%

Operating Profit Margin (Excl OI)

-3,050.30%

207.40%

-325.77%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2023 is -88.46% vs 188.89% in Dec 2022

Consolidated Net Profit

YoY Growth in year ended Dec 2023 is -311.11% vs 0.00% in Dec 2022

All Annual Results

Company CV

About Net Medical Xpress Solutions, Inc.

Net Medical Xpress Solutions, Inc.

Software Products

No Details Available.

Company Coordinates

No Company Details Available